← Back to Search

Supervised Walking Assistance for Limited Mobility in Older Patients

N/A

Recruiting

Led By Michael Rothberg, M.D.

Research Sponsored by The Cleveland Clinic

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Insurance with Traditional Medicare or Medicare Advantage

6-Clicks score of 16-22

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 30 days from admission

Awards & highlights

Study Summary

This trial aims to compare outcomes of medical patients given supervised ambulation vs. usual care, identify who benefits most, and assess cost impacts.

Who is the study for?

This trial is for people aged 65 or older who are admitted to a medical service, have completed necessary health checks, and have a certain level of mobility. They must be insured with Traditional Medicare or Medicare Advantage. It's not for those with significant language barriers (except Spanish at Baystate), planned discharges, upcoming surgeries, severe heart conditions, long-term nursing home residents, on comfort care only, admitted over 48 hours ago, or with active infections requiring isolation.Check my eligibility

What is being tested?

The study tests if having a Mobility Technician help patients walk up to three times daily improves health outcomes compared to usual hospital care. The focus is on the benefits and costs during the hospital stay and the first month after joining the study.See study design

What are the potential side effects?

Since this intervention involves assisted walking exercises by trained technicians rather than medication or surgery, side effects may include general fatigue or discomfort from increased activity but are expected to be minimal.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am covered by Traditional Medicare or Medicare Advantage.

Select...

My mobility score is between 16 and 22.

Select...

I am 65 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 30 days from admission

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~30 days from admission

This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days from admission for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Short Physical Performance Battery (SPPB) from admission

Secondary outcome measures

Activities of Daily Living

Activity Measure for Post-Acute Care (AM-PAC) basic mobility outpatient short form (SF)

Frailty

+7 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Mobility TechnicianExperimental Treatment1 Intervention

Designated mobility technicians (MT) will ambulate hospitalized medical patients up to 3 times daily, 7 days per week, until discharge or a maximum of 10 days. Each day, the MT will visit the patient 4 times or until the patient successfully ambulates 3 times that day. In cases where a PT has provided a recommendation in the patient's chart, the MT will follow the recommendation, if feasible. Otherwise, the MT will execute the standard mobility protocol. The mobility protocol will allow the MT to assist a patient with an appropriate out-of-bed activity based on their 6-clicks score from the immediately preceding session

Group II: Usual CareActive Control1 Intervention

No intervention

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH

1,675 Previous Clinical Trials

28,017,885 Total Patients Enrolled

4 Trials studying Muscle Weakness

592 Patients Enrolled for Muscle Weakness

The Cleveland ClinicLead Sponsor

1,030 Previous Clinical Trials

1,362,558 Total Patients Enrolled

Michael Rothberg, M.D.Principal InvestigatorThe Cleveland Clinic

1 Previous Clinical Trials

12,500 Total Patients Enrolled

Media Library

Mobility technician Clinical Trial Eligibility Overview. Trial Name: NCT05725928 — N/A

Muscle Weakness Research Study Groups: Usual Care, Mobility Technician

Muscle Weakness Clinical Trial 2023: Mobility technician Highlights & Side Effects. Trial Name: NCT05725928 — N/A

Mobility technician 2023 Treatment Timeline for Medical Study. Trial Name: NCT05725928 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many volunteers are being accepted into this clinical research endeavor?

"Affirmative. The clinicaltrials.gov database confirms that recruitment for this medical trial started on May 15th, 2023 and was most recently updated one week later on the 22nd of May. 3000 patients are required to participate in this study at a single site."

Answered by AI

Are there any vacancies available for participants in this experiment?

"Indeed, clinicaltrials.gov affirms that this medical trial is currently in recruitment mode. It was first published on May 15th 2023 and has been most recently updated on the 22nd of May. The research requires 3000 patients to be enrolled from a single clinic location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients

Michael Rothberg 2023. "Assisted Ambulation to Improve Health Outcomes for Older Medical Inpatients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05725928.